Julia A. Bridge
No Rating Available
(Learn About Our Rating System)

Julia A. Bridge, MD, FACMG

Languages spoken: English

Clinical Locations

Primary Location

Huntsman Cancer Institute - Cancer Hospital South

1950 Circle of Hope
Salt Lake City , UT 84112
801-581-2121
Get Directions

University of Utah Hospital

Pathology
50 N Medical Dr
Salt Lake City , UT 84132
801-581-2121
Get Directions

Specialties

  • Pathology, Anatomical

Board Certification

American Board of Pathology (Sub: Anatomic Path)
American Board of Medical Genetics (Clinical Cytogenetics)

Board Certification and Academic Information

Academic Departments Pathology -Professor (Clinical)
Board Certification
American Board of Pathology (Sub: Anatomic Path)
American Board of Medical Genetics (Clinical Cytogenetics)

Education history

Undergraduate University of Nebraska Omaha B.S.
Undergraduate University of Nebraska Omaha M.D.
Residency Pathology - University of Kansas Medical Center Resident
Fellowship Cytogenetics - University of Nebraska Medical Center Special Fellow
Fellowship Cytogenetics - University of Kansas Medical Center Special Fellow
Fellowship Molecular Biology - Southwest Biomedical Research Institute Fellow

Selected Publications

Journal Article

  1. Rutland CD, Kingsley L, Wang A, Zdravkovic S, Das I, Bremer R, Laser JS, Bridge JA, Bishop JA, Krings G, Chen YY, Bean G (2025). RNA In Situ Hybridization Detection of CRTC1/3::MAML2 Fusions and LINC00473 in Mucoepidermoid Carcinomas and Hidradenomas of Breast, Salivary Glands, and Skin. Modern pathology, 38(7), 100756.
  2. Papke DJ Jr, Chrisinger JSA, French CA, Crymes A, Krivak TC, Estape RE, Seetharam M, Patel RA, O'Connor WN, Chi AW, Gutman P, Singer S, Kim C, Bryant DA, Oberley MJ, Adeyelu T, Bridge JA, Evans M (2025). MAD::NUT Fusion Sarcoma: A Sarcoma Class With NUTM1, NUTM2A, and NUTM2G Fusions and Possibly Distinctive Subtypes. Modern pathology, 38(5), 100729.
  3. Selkin TR, Manucha V, Xu J, Palsgrove D, Bridge JA, Bishop J (2025). Novel BMPR1B::AFF2 in a Sinonasal Region Non-Keratinizing Squamous Cell Carcinoma. Head and neck pathology, 19(1), 111.
  4. O'Connor P, Bridge JA, Meis JM, Cloutier J (2025). Myxoid "pauci-hemosiderotic" fibrolipomatous tumour: a diagnostic challenge. Histopathology, 86(4), 647-649.
  5. Bridge JA, Halling KC, Moncur JT, Souers RJ, Hameed MR, Fernandes H, Roy A, Surrey L, Tafe LJ, Vasalos P, Lopez-Terrada D (2024). RNA Sequencing for Solid Tumor Fusion Gene Detection: Proficiency Testing Practice and Performance Comparison. Archives of pathology & laboratory medicine, 148(5), 538-544.
  6. Machado I, Llombart-Bosch A, Charville GW, Navarro S, Domínguez Franjo MP, Bridge JA, Linos (2024). Sarcomas with EWSR1::Non-ETS Fusion (EWSR1::NFATC2 and EWSR1::PATZ1). Surgical pathology clinics, 17(1), 31-55.
  7. Mezzacappa FM, Smith FK, Zhang W, Gard A, Cabuk FK, Gonzalez-Gomez I, Monforte HL, Liang J, Singh O, Quezado MM, Aldape KD, Gokden M, Bridge JA, Chen (2024). Potential prognostic determinants for FET::CREB fusion-positive intracranial mesenchymal tumor. Acta neuropathologica communications, 12(1), 17.
  8. Machado I, Agaimy A, Giner F, Navarro S, Michal M, Bridge J, Claramunt R, López-Guerrero JA, Alcacer J, Linos K, Llombart-Bosch (2024). The value of GLI1 and p16 immunohistochemistry in the premolecular screening for GLI1-altered mesenchymal neoplasms. Virchows Archiv, 484(5), 765-775.
  9. Surucu A, de Biase D, Ricci C, di Sciascio L, Collins K, Idrees MT, Ebare K, Fiorentino M, Bridge JA, Ulbright TM, Acosta A (2024). Beta-Catenin Alterations in Postchemotherapy Yolk Sac Tumor, Postpubertal-Type With Enteroblastic Features. Modern pathology, 37(7), 100513.
  10. Machado I, Agaimy A, Giner F, Navarro S, Michal M, Bridge J, Claramunt R, López-Guerrero JA, Alcacer J, Linos K, Llombart-Bosch (2024). The value of GLI1 and p16 immunohistochemistry in the premolecular screening for GLI1-altered mesenchymal neoplasms. Virchows Archiv, 484(5), 765-775.
  11. Collins K, Bridge JA, Mehra R, Mannan R, Dickson BC, Lotan TL, Idrees MT, Ulbright TM, Acosta A (2024). Renal epithelioid angiomyolipomas overexpress TFE3 and the TFE3-regulated gene TRIM63 in the absence of TFE3 rearrangement. Virchows Archiv, 485(3), 471-478.
  12. Acosta AM, Fletcher CDM, Sholl LM, van Leenders GJ, Oliva E, Cornejo KM, Repetto F, Collins K, Idrees MT, Hirsch MS, Trpkov K, Ulbright TM, Bridge J (2024). Fluorescence in-situ hybridization assessment of spindle cell-rich testicular sex cord stromal tumors demonstrates multiple chromosomal gains across histologic subtypes. Human pathology, 153, 105652.
  13. Gangahar CN, Dehner CA, Wang DP, Amini B, Hillen T, O'Conor C, Jennings SN, Byrnes K, Montgomery EA, Czerniak BA, Bridge JA, Schroeder MC, Jennings JW, Wang WL, Chrisinger JSA (2023). Intraosseous hibernoma: clinicopathologic and imaging analysis of 18 cases. Histopathology, 83(1), 40-48.
  14. Acosta AM, Bridge JA, Dal Cin PS, Sholl LM, Cornejo KM, Fletcher CDM, Ulbright TM (2023). Inflammatory and Nested Testicular Sex Cord Tumor: A Novel Neoplasm With Aggressive Clinical Behavior and Frequent EWSR1::ATF1 Gene Fusions. Am J Surg Pathol, 47(4), 504-517.
  15. Hagemann IS, Bridge JA, Tafe LJ, Hameed MR, Moncur JT, Bellizzi AM, Dolan M, Vasalos P, Kane ME, Souers RJ, Yemelyanova A (2023). Current Laboratory Testing Practices for Assessment of ERBB2/HER2 in Endometrial Serous Carcinoma and Colorectal Carcinoma. Arch Pathol Lab Med, 147(10), 1148-1157.
  16. Bovée JVMG, Webster F, Amary F, Baumhoer D, Bloem JLH, Bridge JA, Cates JMM, de Alava E, Dei Tos AP, Jones KB, Mahar A, Nielsen GP, Righi A, Wagner AJ, Yoshida A, Fletcher CDM (2023). Datasets for the reporting of primary tumour in bone: recommendations from the International Collaboration on Cancer Reporting (ICCR). Histopathology, 82(4), 531-540.
  17. Machado I, Hosler GA, Traves V, Claramunt R, Sanmartín O, Santonja C, Carvajal N, Zazo S, Requena L, Alfonso VS, Domenech EV, Llombart-Bosch A, Bridge JA, Linos K (2023). Superficial GLI1-amplified mesenchymal neoplasms: Expanding the spectrum of an emerging entity which reaches the realm of dermatopathology. J Cutan Pathol, 50(6), 487-499.
  18. Zota V, Siegal GP, Kelly D, Bridge JA, Berglund A, Bui K, Khalil F, R Reed D, Altiok S, Magliocco A, Bui MM (2023). Validation of PRKCB Immunohistochemistry as a Biomarker for the Diagnosis of Ewing Sarcoma. Fetal Pediatr Pathol, 42(2), 241-252.
  19. Crowley HM, Georgantzoglou N, Tse JY, Williams EA, Mata DA, Martin SS, Guitart J, Bridge JA, Linos (2023). Expanding Our Knowledge of Molecular Pathogenesis in Histiocytoses: Solitary Soft Tissue Histiocytomas in Children With a Novel CLTC::SYK Fusion. The American journal of surgical pathology, 47(10), 1108-1115.
  20. Palsgrove DN, Rooper LM, Stevens TM, Shin C, Damm DD, Gagan J, Bridge JA, Thompson LDR, Koduru PR, Bishop JA (2022). GLI1-Altered Soft Tissue Tumors of the Head and Neck: Frequent Oropharyngeal Involvement, p16 Immunoreactivity, and Detectable Alterations by DDIT3 Break Apart FISH. Head Neck Pathol, 16(4), 1146-1156.
  21. Ramkissoon SH, Fernandes H, Lopez-Terrada DH, Hameed MR, Trembath DG, Bridge JA, Lindeman NI, Souers RJ, Vasalos P, Brat DJ, Moncur JT (2022). Clinical Laboratory Testing Practices in Diffuse Gliomas Prior to Publication of 2021 World Health Organization Classification of Central Nervous System Tumors. Arch Pathol Lab Med, 147(5), 518-524.
  22. Brat DJ, Aldape K, Bridge JA, Canoll P, Colman H, Hameed MR, Harris BT, Hattab EM, Huse JT, Jenkins RB, Lopez-Terrada DH, McDonald WC, Rodriguez FJ, Souter LH, Colasacco C, Thomas NE, Yount MH, van den Bent MJ, Perry A (2022). Molecular Biomarker Testing for the Diagnosis of Diffuse Gliomas. Arch Pathol Lab Med, 146(5), 547-574.
  23. Strait AM, Bridge JA, Iafrate AJ, Li MM, Xu F, Tsongalis GJ, Linos K (2022). Mammary-type Myofibroblastoma with Leiomyomatous Differentiation: A Rare Variant with Potential Pitfalls. Int J Surg Pathol, 30(2), 200-206.
  24. Patton A, Bridge JA, Liebner D, Chung C, Iwenofu OH (2022). A YAP1::TFE3 cutaneous low-grade fibromyxoid neoplasm: A novel entity! Genes Chromosomes Cancer, 61(4), 194-199.
  25. Georgantzoglou N, Green D, Winnick KN, Sumegi J, Charville GW, Bridge JA, Linos K (2022). Molecular investigation of ALK-rearranged epithelioid fibrous histiocytomas identifies CLTC as a novel fusion partner and evidence of fusion-independent transcription activation. Genes Chromosomes Cancer, 61(8), 471-480.
  26. Lindsey MS, Bridge JA, Douglas DS, Foster JT, Shalin SC, Gardner JM (2022). Primary Cutaneous Alveolar Rhabdomyosarcoma in an Elderly Adult: A Rare Potential Mimic of Merkel Cell Carcinoma. Am J Dermatopathol, 44(3), 218-222.
  27. Campbell K, Bridge JA, DiMaio D, Wilson J, Shalin SC, Gardner JM (2022). Dermatofibrosarcoma protuberans with platelet-derived growth factor-D rearrangement; two cases with morphologically distinct presentations. J Cutan Pathol, 49(3), 274-277.
  28. Kerr DA, Thompson LDR, Tafe LJ, Jo VY, Neyaz A, Divakar P, Paydarfar JA, Pastel DA, Shirai K, John I, Seethala RR, Salgado CM, Deshpande V, Bridge JA, Kashofer K, Br'i¿ I, Linos K (2021). Clinicopathologic and Genomic Characterization of Inflammatory Myofibroblastic Tumors of the Head and Neck: Highlighting a Novel Fusion and Potential Diagnostic Pitfall. Am J Surg Pathol, 45(12), 1707-1719.
  29. Cowan B, Klein E, Jansz K, Westenfelder K, Bradford T, Peterson C, Scherr D, Karsh LI, Egerdie B, Witjes A, Trainer A, Harris R, Goldfarb B, Flax S, Kroeger R, Boyd B, Liao J, Patel S, Bridge J, Reuter V, Quigley N, Brown S, Zhao S, Satya M, Bates M, Simon IM, Campbell S, Lotan Y (2021). Longitudinal follow-up and performance validation of an mRNA-based urine test (Xpert(®) Bladder Cancer Monitor ) for surveillance in patients with non-muscle-invasive bladder cancer. BJU Int, 128(6), 713-721.
  30. Hughes CE, Correa H, Benedetti DJ, Smith B, Sumegi J, Bridge J (2021). Second Report of PDE10A-BRAF Fusion in Pediatric Spindle Cell Sarcoma With Infantile Fibrosarcoma-Like Morphology Suggesting PDE10A-BRAF Fusion Is a Recurrent Event. Pediatr Dev Pathol, 24(6), 554-558.
  31. Al-Obaidy KI, Bridge JA, Cheng L, Sumegi J, Reuter VE, Benayed R, Hameed M, Williamson SR, Hes O, Alruwaii FI, Segal JP, Wanjari P, Idrees MT, Nassiri M, Eble JN, Grignon DJ (2021). EWSR1-PATZ1 fusion renal cell carcinoma: a recurrent gene fusion characterizing thyroid-like follicular renal cell carcinoma. Mod Pathol, 34(10), 1921-1934.
  32. Sadaf A, Szabo S, Ferguson K, Sorger JI, Sumegi J, Bridge JA, Pressey JG (2021). Novel ARHGAP23-FER fusion in a metastatic spindle cell-predominant neoplasm with a myofibroblastic phenotype and a sustained metabolic response to lorlatinib. Cancer, 127(22), 4124-4130.
  33. Parra O, Bridge JA, Busam KJ, Shalin SC, Linos K (2021). Dermal melanocytic tumor with CRTC1-TRIM11 fusion: Report of two additional cases with review of the literature of an emerging entity. J Cutan Pathol, 48(7), 915-924.
  34. Wang H, Weiss VL, Hoffman RD, Abel T, Ho RH, Borinstein SC, Mannion K, Bridge JA, Black J, Liang J (2021). Salivary Gland NUT Carcinoma with Prolonged Survival in Children: Case Illustration and Systematic Review of Literature. Head Neck Pathol, 15(1), 236-243.
  35. Valenberg FJPV, Hiar AM, Wallace E, Bridge JA, Mayne DJ, Beqaj S, Sexton WJ, Lotan Y, Weizer AZ, Jansz GK, Stenzl A, Danella JF, Cline KJ, Williams MB, Montgomery S, David RD, Harris R, Klein EW, Bradford TJ, Wolk FN, Westenfelder KR, Trainer AF, Richardson TA, Egerdie RB, Goldfarb B, Zadra JA, Lu X, Simon IM, Campbell SA, Bates MP, Higuchi RG, Witjes JA (2021). Validation of an mRNA-based Urine Test for the Detection of Bladder Cancer in Patients with Haematuria. Eur Urol Oncol, 4(1), 93-101.
  36. Linos K, Kerr DA, Sumegi J, Bridge JA (2021). Pan-Trk immunoexpression in a superficial malignant ossifying fibromyxoid tumor with ZC3H7B-BCOR fusion: A potential obfuscating factor in the era of targeted therapy. J Cutan Pathol, 48(2), 340-342.
  37. Motanagh S, Bridge JA, Linos K (2021). Acral fibromyxoma with loss of Rb1 by immunohistochemistry and fluorescence in situ hybridization: A diagnostically exploitable marker. J Cutan Pathol, 48(2), 295-301.
  38. Pettus JR, Kerr DA, Stan RV, Tse JY, Sverrisson EF, Bridge JA, Linos K (2021). Primary myxoid and epithelioid mesenchymal tumor of the kidney with a novel GLI1-FOXO4 fusion. Genes Chromosomes Cancer, 60(2), 116-122.
  39. Bridge JA, Sumegi J, Royce T, Baker M, Linos K (2021). A novel CLTC-FOSB gene fusion in pseudomyogenic hemangioendothelioma of bone. Genes Chromosomes Cancer, 60(1), 38-42.
  40. Parra O, Kerr DA, Bridge JA, Loehrer AP, Linos K (2021). A case of YAP1 and NUTM1 rearranged porocarcinoma with corresponding immunohistochemical expression: Review of recent advances in poroma and porocarcinoma pathogenesis with potential diagnostic utility. J Cutan Pathol, 48(1), 95-101.
  41. Tran TAN, Bridge JA, Deharvengt SJ, Green DC, Linos K (2020). Primary Cutaneous Adenomyoepithelioma Ex Spiradenoma With Malignant Histologic Features, Epithelial-Myoepithelial Carcinoma Type: A First Case Report With Molecular Studies. Int J Surg Pathol, 28(4), 427-435.
  42. Mindiola-Romero AE, Maloney N, Bridge JA, Korkolopoulou P, Sakellariou S, Linos K (2020). A concise review of angiofibroma of soft tissue: A rare newly described entity that can be encountered by dermatopathologists. J Cutan Pathol, 47(2), 179-185.
  43. Keegan A, Bridge JA, Lindeman NI, Long TA, Merker JD, Moncur JT, Montgomery ND, Nagarajan R, Rothberg PG, Routbort MJ, Vasalos P, Xian R, Kim AS (2020). Proficiency Testing of Standardized Samples Shows High Interlaboratory Agreement for Clinical Next Generation Sequencing-Based Hematologic Malignancy Assays With Survey Material-Specific Differences in Variant Frequencies.(Epub ahead of print). Arch Pathol Lab Med.
  44. Zhang L, Hwang S, Benayed R, Zhu GG, Mullaney KA, Rios KM, Sukhadia PY, Agaram N, Zhang Y, Bridge JA, Healey JH, Athanasian EA, Hameed M (2020). Myositis ossificans-like soft tissue aneurysmal bone cyst: a clinical, radiological, and pathological study of seven cases with COL1A1-USP6 fusion and a novel ANGPTL2-USP6 fusion. Mod Pathol, 33(8), 1492-1504.
  45. Nguyen JK, Bridge JA, Joshi C, McKenney JK (2019). Primary Mammary Analog Secretory Carcinoma (MASC) of the Vulva With ETV6-NTRK3 Fusion: A Case Report. Int J Gynecol Pathol, 38(3), 283-287.
  46. Castillo SA, Pham AK, Barton DT, Lefferts JA, Yan S, Bridge JA, Linos K (2019). A diagnostically-challenging case of melanoma ex blue nevus with comprehensive molecular analysis, including the 23-gene expression signature (myPath melanoma). J Cutan Pathol, 46(3), 226-230.
  47. Maloley L, Helvey J, Bridge J, DiMaio D, Ghate D, Kedar S (2019). A Tough NUT to Crack: A 47-Year-Old With Diplopia From a Rare Malignancy. J Neuroophthalmol, 39(1), 129-133.
  48. Tran TAN, Linos K, Carlson JA, Bridge JA (2019). A primary cutaneous vascular neoplasm with histologic features of anastomosing hemangioma. J Cutan Pathol, 46(5), 353-357.
  49. MacKinnon WF, Carter MD, Bridge JA, Tremaine RD, Walsh NMG (2019). EWSR1-PBX3 gene fusion in cutaneous syncytial myoepithelioma. J Cutan Pathol, 46(6), 421-424.
  50. Stevens TM, Morlote D, Xiu J, Swensen J, Brandwein-Weber M, Miettinen MM, Gatalica Z, Bridge JA (2019). NUTM1-rearranged neoplasia: a multi-institution experience yields novel fusion partners and expands the histologic spectrum. Mod Pathol, 32(6), 764-773.
  51. Perkins AR, Macaulay RJB, Bui MM, Bridge JA, Etame AB (2019). A Frontal Dural-Based Lesion in a 63-Year Old Male. Brain Pathol, 29(2), 301-302.
  52. Valenberg FJPV, Hiar AM, Wallace E, Bridge JA, Mayne DJ, Beqaj S, Sexton WJ, Lotan Y, Weizer AZ, Jansz GK, Stenzl A, Danella JF, Shepard B, Cline KJ, Williams MB, Montgomery S, David RD, Harris R, Klein EW, Bradford TJ, Wolk FN, Westenfelder KR, Trainer AF, Richardson TA, Egerdie RB, Goldfarb B, Zadra JA, Ge S, Zhao S, Simon IM, Campbell SA, Rhees B, Bates MP, Higuchi RG, Witjes JA (2019). Prospective Validation of an mRNA-based Urine Test for Surveillance of Patients with Bladder Cancer. Eur Urol, 75(5), 853-860.
  53. Moncur JT, Bartley AN, Bridge JA, Kamel-Reid S, Lazar AJ, Lindeman NI, Long TA, Merker JD, Rai AJ, Rimm DL, Rothberg PG, Vasalos P, Kim AS (2019). Performance Comparison of Different Analytic Methods in Proficiency Testing for Mutations in the BRAF, EGFR, and KRAS Genes: A Study of the College of American Pathologists Molecular Oncology Committee. Arch Pathol Lab Med, 143(10), 1203-1211.
  54. Maloney N, Bridge JA, de Abreu F, Korkolopoulou P, Sakellariou S, Linos K (2019). A novel MAP3K7CL-ERG fusion in a molecularly confirmed case of dermatofibrosarcoma protuberans with fibrosarcomatous transformation. J Cutan Pathol, 46(7), 532-537.
  55. Bridge JA, Sumegi J, Druta M, Bui MM, Henderson-Jackson E, Linos K, Baker M, Walko CM, Millis S, Brohl AS (2019). Clinical, pathological, and genomic features of EWSR1-PATZ1 fusion sarcoma. Mod Pathol, 32(11), 1593-1604.
  56. Maloney N, LeBlanc RE, Sriharan A, Bridge JA, Linos K (2019). Superficial Nodular Fasciitis With Atypical Presentations: Report of 3 Cases and Review of Recent Molecular Genetics. Am J Dermatopathol, 41(12), 931-936.
  57. Borinstein SC, Steppan D, Hayashi M, Loeb DM, Isakoff MS, Binitie O, Brohl AS, Bridge JA, Stavas M, Shinohara ET, Meyer WH, Reed DR, Wagner LM (2018). Consensus and controversies regarding the treatment of rhabdomyosarcoma. Pediatr Blood Cancer, 65(2).
  58. Wallace E, Higuchi R, Satya M, McCann L, Sin MLY, Bridge JA, Wei H, Zhang J, Wong E, Hiar A, Mach KE, Scherr D, Egerdie RB, Ohta S, Sexton WJ, Meng MV, Weizer AZ, Woods M, Jansz GK, Zadra J, Lotan Y, Goldfarb B, Liao JC (2018). Development of a 90-Minute Integrated Noninvasive Urinary Assay for Bladder Cancer Detection. J Urol, 199(3), 655-662.
  59. Hollowoa B, Lamps LW, Mizell JS, English GW 3rd, Bridge JA, Ram R, Gardner JM (2018). Dedifferentiated Liposarcoma Mimicking a Primary Colon Mass. Int J Surg Pathol, 26(2), 174-179.
  60. Kim AS, Bartley AN, Bridge JA, Kamel-Reid S, Lazar AJ, Lindeman NI, Long TA, Merker JD, Rai AJ, Rimm DL, Rothberg PG, Vasalos P, Moncur JT (2018). Comparison of Laboratory-Developed Tests and FDA-Approved Assays for BRAF, EGFR, and KRAS Testing. JAMA Oncol, 4(6), 838-841.
  61. Maloney N, Giannikou K, Lefferts J, Bridge JA, Linos K (2018). Expanding the histomorphologic spectrum of TFE3-rearranged perivascular epithelioid cell tumors. Hum Pathol, 82, 125-130.
  62. Laetsch TW, Roy A, Xu L, Black JO, Coffin CM, Chi YY, Tian J, Spunt SL, Hawkins DS, Bridge JA, Parsons DW, Skapek SX (2018). Undifferentiated Sarcomas in Children Harbor Clinically Relevant Oncogenic Fusions and Gene Copy-Number Alterations: A Report from the Children's Oncology Group. Clin Cancer Res, 24(16), 3888-3897.
  63. Geiersbach KB, Bridge JA, Dolan M, Jennings LJ, Persons DL, Souers RJ, Tsuchiya KD, Vasalos PH, Moncur JT (2018). Comparative Performance of Breast Cancer Human Epidermal Growth Factor Receptor 2 Fluorescence In Situ Hybridization and Brightfield In Situ Hybridization on College of American Pathologists Proficiency Tests. Arch Pathol Lab Med, 142(10), 1254-1259.
  64. Olson N, Rouhi O, Zhang L, Angeles C, Bridge J, Lopez-Terrada D, Royce T, Linos K (2018). A novel case of an aggressive superficial spindle cell sarcoma in an adult resembling fibrosarcomatous dermatofibrosarcoma protuberans and harboring an EML4-NTRK3 fusion. J Cutan Pathol, 45(12), 933-939.
  65. Tao JJ, Wei G, Patel R, Fagan P, Hao X, Bridge JA, Arcila ME, Al-Ahmadie H, Lee CH, Li G, Drilon A (2018). ALK Fusions in Renal Cell Carcinoma: Response to Entrectinib. JCO Precis Oncol, 2, 1-8.
  66. Rimm DL, Han G, Taube JM, Yi ES, Bridge JA, Flieder DB, Homer R, West WW, Wu H, Roden AC, Fujimoto J, Yu H, Anders R, Kowalewski A, Rivard C, Rehman J, Batenchuk C, Burns V, Hirsch FR, Wistuba II (2017). A Prospective, Multi-institutional, Pathologist-Based Assessment of 4 Immunohistochemistry Assays for PD-L1 Expression in Non-Small Cell Lung Cancer. JAMA Oncol, 3(8), 1051-1058.
  67. Dettloff J, Seethala RR, Stevens TM, Brandwein-Gensler M, Centeno BA, Otto K, Bridge JA, Bishop JA, Leon ME (2017). Regarding Bocklage et al. "Regarding Dettloff et al. Mammary Analog Secretory Carcinoma (MASC) Involving the Thyroid Gland: A Report of First 3 Cases". Head Neck Pathol, 11(2), 266-267.
  68. Dettloff J, Seethala RR, Stevens TM, Brandwein-Gensler M, Centeno BA, Otto K, Bridge JA, Bishop JA, Leon ME (2017). Mammary Analog Secretory Carcinoma (MASC) Involving the Thyroid Gland: A Report of the First 3 Cases. Head Neck Pathol, 11(2), 124-130.
  69. Hery AL, Ornvold K, Memoli V, Bridge J, Linos K (2017). A case of CIC-rearranged undifferentiated round-cell sarcoma with exclusive spindled morphology and diffuse CD99 positivity: a potential pitfall. Histopathology, 70(2), 314-316.
  70. Kuba MG, Wasserman A, Vnencak-Jones CL, Bridge JA, Gellert L, Hameed O, Giannico GA (2017). Primary Carcinoid Tumor of the Renal Pelvis Arising From Intestinal Metaplasia: An Unusual Histogenetic Pathway? Appl Immunohistochem Mol Morphol, 25(7), e49-e57.
  71. Zajicek AK, Bridge JA, Akers JW, McGarry SV, Walker CW (2017). Dedifferentiated liposarcoma of the lower extremity with low-grade dedifferentiation and low-grade osteosarcomatous component. Skeletal Radiol, 46(2), 265-271.
  72. Reed DR, Hayashi M, Wagner L, Binitie O, Steppan DA, Brohl AS, Shinohara ET, Bridge JA, Loeb DM, Borinstein SC, Isakoff MS (2017). Treatment pathway of bone sarcoma in children, adolescents, and young adults. Cancer, 123(12), 2206-2218.
  73. Bridge JA (2017). Reverse transcription-polymerase chain reaction molecular testing of cytology specimens: Pre-analytic and analytic factors. Cancer Cytopathol, 125(1), 11-19.
  74. McGregor SM, Alikhan MB, John RA, Kotler H, Bridge JA, Mujacic I, Kadri S, Segal J, Krausz T (2017). Melanotic PEComa of the Sinonasal Mucosa With NONO-TFE3 Fusion: An Elusive Mimic of Sinonasal Melanoma. Am J Surg Pathol, 41(5), 717-722.
  75. Simons SA, Bridge JA, Leon ME (2016). Sinonasal small round blue cell tumors: An approach to diagnosis. Semin Diagn Pathol, 33(2), 91-103.
  76. Sholl LM, Andea A, Bridge JA, Cheng L, Davies MA, Ehteshami M, Gangadhar TC, Kamel-Reid S, Lazar A, Raparia K, Siroy A, Watson KL, Members of Cancer Biomarker Reporting Committee, College of American Pathologists (2016). Template for Reporting Results of Biomarker Testing of Specimens From Patients With Melanoma. Arch Pathol Lab Med, 140(4), 355-7.
  77. Kapp JR, Diss T, Spicer J, Gandy M, Schrijver I, Jennings LJ, Li MM, Tsongalis GJ, de Castro DG, Bridge JA, Wallace A, Deignan JL, Hing S, Butler R, Verghese E, Latham GJ, Hamoudi RA (2015). Variation in pre-PCR processing of FFPE samples leads to discrepancies in BRAF and EGFR mutation detection: a diagnostic RING trial. J Clin Pathol, 68(2), 111-8.
  78. Lerman DM, Monument MJ, McIlvaine E, Liu XQ, Huang D, Monovich L, Beeler N, Gorlick RG, Marina NM, Womer RB, Bridge JA, Krailo MD, Randall RL, Lessnick SL, Children's Oncology Group Ewing Sarcoma Biology Committee (2015). Tumoral TP53 and/or CDKN2A alterations are not reliable prognostic biomarkers in patients with localized Ewing sarcoma: a report from the Children's Oncology Group. Pediatr Blood Cancer, 62(5), 759-65.
  79. Cykowski MD, Hicks J, Sandberg DI, Olar A, Bridge JA, Greipp PT, Navarro P, Kolodziej S, Bhattacharjee MB (2015). Brain metastasis of crystal-deficient, CD68-positive alveolar soft part sarcoma: ultrastructural features and differential diagnosis. Ultrastruct Pathol, 39(1), 69-77.
  80. Smith SM, Coleman J, Bridge JA, Iwenofu OH (2015). Molecular diagnostics in soft tissue sarcomas and gastrointestinal stromal tumors. J Surg Oncol, 111(5), 520-31.
  81. Pages M, Lacroix L, Tauziede-Espariat A, Castel D, Daudigeos-Dubus E, Ridola V, Gilles S, Fina F, Andreiuolo F, Polivka M, Lechapt-Zalcman E, Puget S, Boddaert N, Liu XQ, Bridge JA, Grill J, Chretien F, Varlet P (2015). Papillary glioneuronal tumors: histological and molecular characteristics and diagnostic value of SLC44A1-PRKCA fusion. Acta Neuropathol Commun, 3, 85.
  82. Boyle TA, Bridge JA, Sabatini LM, Nowak JA, Vasalos P, Jennings LJ, Halling KC, College of American Pathologists Molecular Oncology Committee (2014). Summary of microsatellite instability test results from laboratories participating in proficiency surveys: proficiency survey results from 2005 to 2012. Arch Pathol Lab Med, 138(3), 363-70.
  83. Smith NE, Deyrup AT, Mariño-Enriquez A, Fletcher JA, Bridge JA, Illei PB, Netto GJ, Argani P (2014). VCL-ALK renal cell carcinoma in children with sickle-cell trait: the eighth sickle-cell nephropathy? Am J Surg Pathol, 38(6), 858-63.
  84. Kohsaka S, Shukla N, Ameur N, Ito T, Ng CK, Wang L, Lim D, Marchetti A, Viale A, Pirun M, Socci ND, Qin LX, Sciot R, Bridge J, Singer S, Meyers P, Wexler LH, Barr FG, Dogan S, Fletcher JA, Reis-Filho JS, Ladanyi M (2014). A recurrent neomorphic mutation in MYOD1 defines a clinically aggressive subset of embryonal rhabdomyosarcoma associated with PI3K-AKT pathway mutations. Nat Genet, 46(6), 595-600.
  85. Monument MJ, Johnson KM, McIlvaine E, Abegglen L, Watkins WS, Jorde LB, Womer RB, Beeler N, Monovich L, Lawlor ER, Bridge JA, Schiffman JD, Krailo MD, Randall RL, Lessnick SL (2014). Clinical and biochemical function of polymorphic NR0B1 GGAA-microsatellites in Ewing sarcoma: a report from the Children's Oncology Group. PLoS One, 9(8), e104378.
  86. Gosmann C, Mattarollo SR, Bridge JA, Frazer IH, Blumenthal A (2014). IL-17 suppresses immune effector functions in human papillomavirus-associated epithelial hyperplasia. J Immunol, 193(5), 2248-57.
  87. Rudzinski ER, Anderson JR, Lyden ER, Bridge JA, Barr FG, Gastier-Foster JM, Bachmeyer K, Skapek SX, Hawkins DS, Teot LA, Parham DM (2014). Myogenin, AP2ß, NOS-1, and HMGA2 are surrogate markers of fusion status in rhabdomyosarcoma: a report from the soft tissue sarcoma committee of the children's oncology group. Am J Surg Pathol, 38(5), 654-9.
  88. Bridge JA (2014). The role of cytogenetics and molecular diagnostics in the diagnosis of soft-tissue tumors. Mod Pathol, 27 Suppl 1, S80-97.
  89. Smith RE, Kebriaei MA, Gard AP, McComb RD, Bridge JA, Lennarson PJ (2014). Intracranial malignant triton tumor in a patient with neurofibromatosis type 1: case report and review of the literature. Brain Tumor Pathol, 31(2), 149-54.
  90. Pauli C, Fuchs B, Pfirrmann C, Bridge JA, Hofer S, Bode B (2014). Response of an aggressive periosteal aneurysmal bone cyst (ABC) of the radius to denosumab therapy. World J Surg Oncol, 12, 17.
  91. Perry AM, Nelson M, Sanger WG, Bridge JA, Greiner TC (2013). Cytogenetic abnormalities in follicular dendritic cell sarcoma: report of two cases and literature review. In Vivo, 27(2), 211-4.
  92. Bridge JA, Liu XQ, Sumegi J, Nelson M, Reyes C, Bruch LA, Rosenblum M, Puccioni MJ, Bowdino BS, McComb RD (2013). Identification of a novel, recurrent SLC44A1-PRKCA fusion in papillary glioneuronal tumor. Brain Pathol, 23(2), 121-8.
  93. Donnelly AD, Mukherjee MS, Lyden ER, Bridge JA, Lele SM, Wright N, McGaughey MF, Culberson AM, Horn AJ, Wedel WR, Radio SJ (2013). Optimal z-axis scanning parameters for gynecologic cytology specimens. J Pathol Inform, 4, 38.
  94. Cate F, Bridge JA, Crispens MA, Keedy VL, Troutman A, Coffin CM, Fadare O (2013). Composite uterine neoplasm with embryonal rhabdomyosarcoma and primitive neuroectodermal tumor components: rhabdomyosarcoma with divergent differentiation, variant of primitive neuroectodermal tumor, or unique entity? Hum Pathol, 44(4), 656-63.
  95. Bridge JA, Liu XQ, Sumegi J, Nelson M, Reyes C, Bruch LA, Rosenblum M, Puccioni MJ, Bowdino BS, McComb RD (2013). Identification of a novel, recurrent SLC44A1-PRKCA fusion in papillary glioneuronal tumor. Brain Pathol, 23(2), 121-8.
  96. Skapek SX, Anderson J, Barr FG, Bridge JA, Gastier-Foster JM, Parham DM, Rudzinski ER, Triche T, Hawkins DS (2013). PAX-FOXO1 fusion status drives unfavorable outcome for children with rhabdomyosarcoma: a children's oncology group report. Pediatr Blood Cancer, 60(9), 1411-7.
  97. Demicco EG, Wang WL, Madewell JE, Huang D, Bui MM, Bridge JA, Meis JM (2013). Osseous myxochondroid sarcoma: a detailed study of 5 cases of extraskeletal myxoid chondrosarcoma of the bone. Am J Surg Pathol, 37(5), 752-62.
  98. Rudzinski ER, Teot LA, Anderson JR, Moore J, Bridge JA, Barr FG, Gastier-Foster JM, Skapek SX, Hawkins DS, Parham DM (2013). Dense pattern of embryonal rhabdomyosarcoma, a lesion easily confused with alveolar rhabdomyosarcoma: a report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group. Am J Clin Pathol, 140(1), 82-90.
  99. Nestheide S, Bridge JA, Barnes M, Frayer R, Sumegi J (2013). Pharmacologic inhibition of epigenetic modification reveals targets of aberrant promoter methylation in Ewing sarcoma. Pediatr Blood Cancer, 60(9), 1437-46.
  100. Viray H, Li K, Long TA, Vasalos P, Bridge JA, Jennings LJ, Halling KC, Hameed M, Rimm DL (2013). A prospective, multi-institutional diagnostic trial to determine pathologist accuracy in estimation of percentage of malignant cells. Arch Pathol Lab Med, 137(11), 1545-9.
  101. Edgar MA, Lauer SR, Bridge JA, Rizzo M (2013). Soft tissue angiofibroma: report of 2 cases of a recently described tumor. Hum Pathol, 44(3), 438-41.
  102. Coleman MA, Bridge JA, Lane SW, Dixon CM, Hill GR, Wells JW, Thomas R, Steptoe RJ (2013). Tolerance induction with gene-modified stem cells and immune-preserving conditioning in primed mice: restricting antigen to differentiated antigen-presenting cells permits efficacy. Blood, 121(6), 1049-58.
  103. Bridge JA, Sanders K, Huang D, Nelson M, Neff JR, Muirhead D, Walker C, Seemayer TA, Sumegi J (2012). Pericytoma with t(7;12) and ACTB-GLI1 fusion arising in bone. Hum Pathol, 43(9), 1524-9.
  104. Shulman SC, Katzenstein H, Bridge J, Bannister LL, Qayed M, Oskouei S, Shehata BM (2012). Ewing sarcoma with 7;22 translocation: three new cases and clinicopathological characterization. Fetal Pediatr Pathol, 31(6), 341-8.
  105. Kesserwan C, Sokolic R, Cowen EW, Garabedian E, Heselmeyer-Haddad K, Lee CC, Pittaluga S, Ortiz C, Baird K, Lopez-Terrada D, Bridge J, Wayne AS, Candotti F (2012). Multicentric dermatofibrosarcoma protuberans in patients with adenosine deaminase-deficient severe combined immune deficiency. J Allergy Clin Immunol, 129(3), 762-769.e1.
  106. Dumont SN, Lazar AJ, Bridge JA, Benjamin RS, Trent JC (2012). PAX3/7-FOXO1 fusion status in older rhabdomyosarcoma patient population by fluorescent in situ hybridization. J Cancer Res Clin Oncol, 138(2), 213-20.
  107. King L, López-Terrada D, Jakacky J, McCarville MB, Spunt SL, Bridge JA, Bahrami A (2012). Primary intrathoracic dermatofibrosarcoma protuberans. Am J Surg Pathol, 36(12), 1897-902.
  108. Bowen JM, Cates JM, Kash S, Itani D, Gonzalez A, Huang D, Oliveira A, Bridge JA (2012). Genomic imbalances in benign metastasizing leiomyoma: characterization by conventional karyotypic, fluorescence in situ hybridization, and whole genome SNP array analysis. Cancer Genet, 205(5), 249-54.
  109. Behery RE, Bedrnicek J, Lazenby A, Nelson M, Grove J, Huang D, Smith R, Bridge J (2012). Translocation t(12;17)(q24.1;q21) as the sole anomaly in a nasal chondromesenchymal hamartoma arising in a patient with pleuropulmonary blastoma. Pediatric and developmental pathology, 15(3), 249-53.
  110. Pan Z, Sanger WG, Bridge JA, Hunter WJ, Siegal GP, Wei (2012). A novel t(6;13)(q15;q34) translocation in a giant cell reparative granuloma (solid aneurysmal bone cyst). Human pathology, 43(6), 952-7.
  111. Wang L, Motoi T, Khanin R, Olshen A, Mertens F, Bridge J, Dal Cin P, Antonescu CR, Singer S, Hameed M, Bovee JV, Hogendoorn PC, Socci N, Ladanyi (2012). Identification of a novel, recurrent HEY1-NCOA2 fusion in mesenchymal chondrosarcoma based on a genome-wide screen of exon-level expression data. Genes, chromosomes & cancer, 51(2), 127-39.
  112. Steelman C, Katzenstein H, Parham D, Stockwell C, Ricketts R, Abramowsky C, Bridge JA, Sorensen PH, Kenney B, Olson T, Igbokwe A, Lopez-Terrada D, Shehata (2011). Unusual presentation of congenital infantile fibrosarcoma in seven infants with molecular-genetic analysis. Fetal and pediatric pathology, 30(5), 329-37.
  113. Bridge JA, Cushman-Vokoun A (2011). Molecular diagnostics of soft tissue tumors. Archives of pathology & laboratory medicine, 135(5), 588-601.
  114. Yu J, Deshmukh H, Payton JE, Dunham C, Scheithauer BW, Tihan T, Prayson RA, Guha A, Bridge JA, Ferner RE, Lindberg GM, Gutmann RJ, Emnett RJ, Salavaggione L, Gutmann DH, Nagarajan R, Watson MA, Perry (2011). Array-based comparative genomic hybridization identifies CDK4 and FOXM1 alterations as independent predictors of survival in malignant peripheral nerve sheath tumor. Clinical cancer research, 17(7), 1924-34.
  115. Shehata BM, Gupta NA, Katzenstein HM, Steelman CK, Wulkan ML, Gow KW, Bridge JA, Kenney BD, Thompson K, de Chadarévian JP, Abramowsky C (2011). Undifferentiated embryonal sarcoma of the liver is associated with mesenchymal hamartoma and multiple chromosomal abnormalities: a review of eleven cases. Pediatric and developmental pathology, 14(2), 111-6.
  116. Riddle ND, Gonzalez RJ, Bridge JA, Antonia S, Bui M (2011). A CD117 and CD34 immunoreactive sarcoma masquerading as a gastrointestinal stromal tumor: diagnostic pitfalls of ancillary studies in sarcoma. Cancer control, 18(3), 152-9.
  117. Sumegi J, Nishio J, Nelson M, Frayer RW, Perry D, Bridge J (2011). A novel t(4;22)(q31;q12) produces an EWSR1-SMARCA5 fusion in extraskeletal Ewing sarcoma/primitive neuroectodermal tumor. Modern pathology, 24(3), 333-42.
  118. Debelenko LV, Raimondi SC, Daw N, Shivakumar BR, Huang D, Nelson M, Bridge J (2011). Renal cell carcinoma with novel VCL-ALK fusion: new representative of ALK-associated tumor spectrum. Modern pathology, 24(3), 430-42.
  119. Bowe SN, Ozer E, Bridge JA, Brooks JS, Iwenofu O (2011). Primary intranodal epithelioid rhabdomyosarcoma. American journal of clinical pathology, 136(4), 587-92.
  120. Yasuda T, Suzuki K, Kanamori M, Hori T, Huang D, Bridge JA, Kimura (2011). Extraskeletal Ewing's sarcoma of the thoracic epidural space: case report and review of the literature. Oncology reports, 26(3), 711-5.
  121. Gatalica Z, Lilleberg SL, Monzon FA, Koul MS, Bridge JA, Knezetic J, Legendre B, Sharma P, McCue P (2011). Renal medullary carcinomas: histopathologic phenotype associated with diverse genotypes. Human pathology, 42(12), 1979-88.
  122. Hou J, Dong J, Sun L, Geng L, Wang J, Zheng J, Li Y, Bridge J, Hinrichs SH, Ding S (2011). Inhibition of phosphorylated c-Met in rhabdomyosarcoma cell lines by a small molecule inhibitor SU11274. Journal of translational medicine, 9, 64.
  123. Bridge JA, Bowen JM, Smith R (2010). The small round blue cell tumors of the sinonasal area. Head and neck pathology, 4(1), 84-93.
  124. O'Donnell PH, Jensen A, Posadas EM, Bridge JA, Yeldandi AV, Yang XJ, Stadler WM, Al-Ahmadie (2010). Renal medullary-like carcinoma in an adult without sickle cell hemoglobinopathy. Nature reviews. Urology, 7(2), 110-4.
  125. Sumegi J, Streblow R, Frayer RW, Dal Cin P, Rosenberg A, Meloni-Ehrig A, Bridge J (2010). Recurrent t(2;2) and t(2;8) translocations in rhabdomyosarcoma without the canonical PAX-FOXO1 fuse PAX3 to members of the nuclear receptor transcriptional coactivator family. Genes, chromosomes & cancer, 49(3), 224-36.
  126. Nelson M, Perkins SL, Dave BJ, Coccia PF, Bridge JA, Lyden ER, Heerema NA, Lones MA, Harrison L, Cairo MS, Sanger W (2010). An increased frequency of 13q deletions detected by fluorescence in situ hybridization and its impact on survival in children and adolescents with Burkitt lymphoma: results from the Children's Oncology Group study CCG-5961. British journal of haematology, 148(4), 600-10.
  127. Nezelof C, Seemayer TA, Bridge J (2010). Contributions of pediatrics and pediatric pathology to the body of knowledge regarding human disease. Human pathology, 41(3), 309-15.
  128. Romeo S, Duim RA, Bridge JA, Mertens F, de Jong D, Dal Cin P, Wijers-Koster PM, Debiec-Rychter M, Sciot R, Rosenberg AE, Szuhai K, Hogendoorn P (2010). Heterogeneous and complex rearrangements of chromosome arm 6q in chondromyxoid fibroma: delineation of breakpoints and analysis of candidate target genes. The American journal of pathology, 177(3), 1365-76.
  129. Huang D, Sumegi J, Dal Cin P, Reith JD, Yasuda T, Nelson M, Muirhead D, Bridge J (2010). C11orf95-MKL2 is the resulting fusion oncogene of t(11;16)(q13;p13) in chondroid lipoma. Genes, chromosomes & cancer, 49(9), 810-8.
  130. Kim HJ, Shen SS, Ayala AG, Ro JY, Truong LD, Alvarez K, Bridge JA, Gatalica Z, Hagenkord JM, Gonzalez-Berjon JM, Monzon F (2009). Virtual-karyotyping with SNP microarrays in morphologically challenging renal cell neoplasms: a practical and useful diagnostic modality. The American journal of surgical pathology, 33(9), 1276-86.
  131. Monzon FA, Alvarez K, Gatalica Z, Bridge JA, Nelson M, Kim HJ, Hagenkord J (2009). Detection of chromosomal aberrations in renal tumors: a comparative study of conventional cytogenetics and virtual karyotyping with single-nucleotide polymorphism microarrays. Archives of pathology & laboratory medicine, 133(12), 1917-22.
  132. Alaggio R, Coffin CM, Weiss SW, Bridge JA, Issakov J, Oliveira AM, Folpe A (2009). Liposarcomas in young patients: a study of 82 cases occurring in patients younger than 22 years of age. The American journal of surgical pathology, 33(5), 645-58.
  133. Yasuda T, Perry KD, Nelson M, Bui MM, Nasir A, Goldschmidt R, Gnepp DR, Bridge J (2009). Alveolar rhabdomyosarcoma of the head and neck region in older adults: genetic characterization and a review of the literature. Human pathology, 40(3), 341-8.
  134. Giannico G, Holt GE, Homlar KC, Johnson J, Pinnt J, Bridge J (2009). Osteoblastoma characterized by a three-way translocation: report of a case and review of the literature. Cancer genetics and cytogenetics, 195(2), 168-71.
  135. Yasuda T, Nishio J, Sumegi J, Kapels KM, Althof PA, Sawyer JR, Reith JD, Bridge J (2009). Aberrations of 6q13 mapped to the COL12A1 locus in chondromyxoid fibroma. Modern pathology, 22(11), 1499-506.
  136. Nugent SL, Dim DC, Bridge JA, Ioffe O (2009). Clear cell sarcoma of soft tissue metastatic to the ovaries: a heretofore unreported occurrence. International journal of gynecological pathology, 28(3), 234-8.
  137. Qualman S, Lynch J, Bridge J, Parham D, Teot L, Meyer W, Pappo (2008). Prevalence and clinical impact of anaplasia in childhood rhabdomyosarcoma : a report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group. Cancer, 113(11), 3242-7.
  138. Camp MD, Tompkins RK, Spanier SS, Bridge JA, Bush C (2008). Best cases from the AFIP: Adamantinoma of the tibia and fibula with cytogenetic analysis. Radiographics, 28(4), 1215-20.
  139. Torabi A, Lele SM, DiMaio D, Pinnt JC, Hess MM, Nelson M, Bridge J (2008). Lack of a common or characteristic cytogenetic anomaly in solitary fibrous tumor. Cancer genetics and cytogenetics, 181(1), 60-4.
  140. Bridge J (2008). Contribution of cytogenetics to the management of poorly differentiated sarcomas. Ultrastructural pathology, 32(2), 63-71.
  141. Rawlinson NJ, West WW, Nelson M, Bridge J (2008). Aggressive angiomyxoma with t(12;21) and HMGA2 rearrangement: report of a case and review of the literature. Cancer genetics and cytogenetics, 181(2), 119-24.
  142. Scanlan D, Radio SJ, Nelson M, Zhou M, Streblow R, Prasad V, Reyes C, Perry D, Fletcher S, Bridge J (2008). Loss of the PTCH1 gene locus in cardiac fibroma. Cardiovascular pathology, 17(2), 93-7.
  143. Bridge J (2008). Advantages and limitations of cytogenetic, molecular cytogenetic, and molecular diagnostic testing in mesenchymal neoplasms. Journal of orthopaedic science, 13(3), 273-82.
  144. Streblow RC, Dafferner AJ, Nelson M, Fletcher M, West WW, Stevens RK, Gatalica Z, Novak D, Bridge J (2007). Imbalances of chromosomes 4, 9, and 12 are recurrent in the thecoma-fibroma group of ovarian stromal tumors. Cancer genetics and cytogenetics, 178(2), 135-40.
  145. Kapels KM, Nishio J, Zhou M, Qualman SJ, Bridge J (2007). Embryonal rhabdomyosarcoma with a der(16)t(1;16) translocation. Cancer genetics and cytogenetics, 174(1), 68-73.
  146. Stevens R, Almanaseer I, Gonzalez M, Caglar D, Knudson RA, Ketterling RP, Schrock DS, Seemayer TA, Bridge J (2007). Analysis of HER2 gene amplification using an automated fluorescence in situ hybridization signal enumeration system. The Journal of molecular diagnostics, 9(2), 144-50.
  147. Ellison DA, Parham DM, Bridge J, Beckwith J (2007). Immunohistochemistry of primary malignant neuroepithelial tumors of the kidney: a potential source of confusion? A study of 30 cases from the National Wilms Tumor Study Pathology Center. Human pathology, 38(2), 205-11.
  148. Sarosdy MF, Kahn PR, Ziffer MD, Love WR, Barkin J, Abara EO, Jansz K, Bridge JA, Johansson SL, Persons DL, Gibson J (2006). Use of a multitarget fluorescence in situ hybridization assay to diagnose bladder cancer in patients with hematuria. The Journal of urology, 176(1), 44-7.
  149. Nishio J, Gentry JD, Neff JR, Nelson M, Daniels W, Perry D, Gatalica Z, Bridge J (2006). Monoallelic deletion of the p53 gene through chromosomal translocation in a small cell osteosarcoma. Virchows Archiv, 448(6), 852-6.
  150. Nishio J, Althof PA, Bailey JM, Zhou M, Neff JR, Barr FG, Parham DM, Teot L, Qualman SJ, Bridge J (2006). Use of a novel FISH assay on paraffin-embedded tissues as an adjunct to diagnosis of alveolar rhabdomyosarcoma. Laboratory investigation; a journal of technical methods and pathology, 86(6), 547-56.
  151. Barker KT, Spendlove HE, Banu NS, Bridge JA, Fisher C, Shipley J, Garrett M, Manyonda I, Houlston R (2006). No evidence for epigenetic inactivation of fumarate hydratase in leiomyomas and leiomyosarcomas. Cancer letters, 235(1), 136-40.
  152. Mazur MA, Gururangan S, Bridge JA, Cummings TJ, Mukundan S, Fuchs H, Larrier N, Halperin E (2005). Intracranial Ewing sarcoma. Pediatric blood & cancer, 45(6), 850-6.
  153. Standop J, Andrianifahanana M, Moniaux N, Schneider M, Ulrich A, Brand RE, Wisecarver JL, Bridge JA, Büchler MW, Adrian TE, Batra SK, Pour P (2005). ErbB2 growth factor receptor, a marker for neuroendocrine cells?. Pancreatology, 5(1), 44-58.
  154. Oliveira AM, Perez-Atayde AR, Dal Cin P, Gebhardt MC, Chen CJ, Neff JR, Demetri GD, Rosenberg AE, Bridge JA, Fletcher J (2005). Aneurysmal bone cyst variant translocations upregulate USP6 transcription by promoter swapping with the ZNF9, COL1A1, TRAP150, and OMD genes. Oncogene, 24(21), 3419-26.
  155. Argani P, Laé M, Hutchinson B, Reuter VE, Collins MH, Perentesis J, Tomaszewski JE, Brooks JS, Acs G, Bridge JA, Vargas SO, Davis IJ, Fisher DE, Ladanyi (2005). Renal carcinomas with the t(6;11)(p21;q12): clinicopathologic features and demonstration of the specific alpha-TFEB gene fusion by immunohistochemistry, RT-PCR, and DNA PCR. The American journal of surgical pathology, 29(2), 230-40.
  156. Caughron SK, Bridge JA, Bewtra CB, Hunter WJ, Nelson M, Soundararajan S, Silva E, Gatalica (2005). Monosomy 22 as a diagnostic aid in a case of late recurrence of adult granulosa cell tumor of the ovary. Cancer genetics and cytogenetics, 156(1), 83-5.
  157. Chiles MC, Parham DM, Qualman SJ, Teot LA, Bridge JA, Ullrich F, Barr FG, Meyer WH, Soft Tissue Sarcoma Committee of Children's Oncology Grou (2005). Sclerosing rhabdomyosarcomas in children and adolescents: a clinicopathologic review of 13 cases from the Intergroup Rhabdomyosarcoma Study Group and Children's Oncology Group. Pediatric and developmental pathology, 8(1), 141.
  158. Nishio J, Reith JD, Ogose A, Maale G, Neff JR, Bridge J (2005). Cytogenetic findings in clear cell chondrosarcoma. Cancer genetics and cytogenetics, 162(1), 74-7.
  159. Olsen RJ, Lydiatt WM, Koepsell SA, Lydiatt D, Johansson SL, Naumann S, Bridge JA, Neff JR, Hinrichs SH, Tarantolo S (2005). C-erb-B2 (HER2/neu) expression in synovial sarcoma of the head and neck. Head & neck, 27(10), 883-92.
  160. Nishio J, Iwasaki H, Nabeshima K, Ishiguro M, Naumann S, Isayama T, Naito M, Kaneko Y, Kikuchi M, Bridge J (2005). Establishment of a new human epithelioid sarcoma cell line, FU-EPS-1: molecular cytogenetic characterization by use of spectral karyotyping and comparative genomic hybridization. International journal of oncology, 27(2), 361-9.
  161. Nishio J, Iwasaki H, Althof PA, Naumann S, Ishiguro M, Haraoka S, Iwashita A, Iwasaki A, Kaku Y, Kaneko Y, Kikuchi M, Bridge J (2005). Identification of a ring chromosome with spectral karyotyping in a pleural synovial sarcoma. Cancer genetics and cytogenetics, 160(2), 174-8.
  162. Bridge RS Jr, Bridge JA, Neff JR, Naumann S, Althof P, Bruch L (2004). Recurrent chromosomal imbalances and structurally abnormal breakpoints within complex karyotypes of malignant peripheral nerve sheath tumour and malignant triton tumour: a cytogenetic and molecular cytogenetic study. Journal of clinical pathology, 57(11), 1172-8.
  163. Deyrup AT, Althof P, Zhou M, Morgan M, Solomon AR, Bridge JA, Weiss S (2004). Paraganglioma-like dermal melanocytic tumor: a unique entity distinct from cellular blue nevus, clear cell sarcoma, and cutaneous melanoma. The American journal of surgical pathology, 28(12), 1579-86.
  164. Cummings TJ, Bridge JA, Fukushima (2004). Extraskeletal myxoid chondrosarcoma of the jugular foramen. Clinical neuropathology, 23(5), 232-7.
  165. Bernal KL, Fahmy L, Remmenga S, Bridge J, Baker (2004). Embryonal rhabdomyosarcoma (sarcoma botryoides) of the cervix presenting as a cervical polyp treated with fertility-sparing surgery and adjuvant chemotherapy. Gynecologic oncology, 95(1), 243-6.
  166. Parham DM, Bridge JA, Lukacs JL, Ding Y, Tryka AF, Sawyer J (2004). Cytogenetic distinction among benign fibro-osseous lesions of bone in children and adolescents: value of karyotypic findings in differential diagnosis. Pediatric and developmental pathology, 7(2), 148-58.
  167. Watson MA, Perry A, Tihan T, Prayson RA, Guha A, Bridge J, Ferner R, Gutmann D (2004). Gene expression profiling reveals unique molecular subtypes of Neurofibromatosis Type I-associated and sporadic malignant peripheral nerve sheath tumors. Brain pathology (Zurich, Switzerland), 14(3), 297-303.
  168. Bernal K, Nelson M, Neff JR, Nielsen SM, Bridge J (2004). Translocation (2;11)(q31;q12) is recurrent in collagenous fibroma (desmoplastic fibroblastoma). Cancer genetics and cytogenetics, 149(2), 161-3.
  169. Oliveira AM, Hsi BL, Weremowicz S, Rosenberg AE, Dal Cin P, Joseph N, Bridge JA, Perez-Atayde AR, Fletcher J (2004). USP6 (Tre2) fusion oncogenes in aneurysmal bone cyst. Cancer research, 64(6), 1920-3.
  170. Althof PA, Ohmori K, Zhou M, Bailey JM, Bridge RS, Nelson M, Neff JR, Bridge J (2004). Cytogenetic and molecular cytogenetic findings in 43 aneurysmal bone cysts: aberrations of 17p mapped to 17p13.2 by fluorescence in situ hybridization. Modern pathology, 17(5), 518-25.
  171. Birch NC, Antonescu CR, Nelson M, Sarran L, Neff JR, Seemayer T, Bridge J (2003). Inconspicuous insertion 22;12 in myxoid/round cell liposarcoma accompanied by the secondary structural abnormality der(16)t(1;16). The Journal of molecular diagnostics, 5(3), 191-4.
  172. Nelson M, Perry D, Ginsburg G, Sanger WG, Neff JR, Bridge J (2003). Translocation (1;4)(p31;q34) in nonossifying fibroma. Cancer genetics and cytogenetics, 142(2), 142-4.
  173. Ma Z, Hill DA, Collins MH, Morris SW, Sumegi J, Zhou M, Zuppan C, Bridge J (2003). Fusion of ALK to the Ran-binding protein 2 (RANBP2) gene in inflammatory myofibroblastic tumor. Genes, chromosomes & cancer, 37(1), 98-105.
  174. Buddingh EP, Naumann S, Nelson M, Neffa JR, Birch N, Bridge J (2003). Cytogenetic findings in benign cartilaginous neoplasms. Cancer genetics and cytogenetics, 141(2), 164-8.
  175. Buddingh EP, Krallman P, Neff JR, Nelson M, Liu J, Bridge J (2003). Chromosome 6 abnormalities are recurrent in synovial chondromatosis. Cancer genetics and cytogenetics, 140(1), 18-22.
  176. Laflamme C, Filion C, Bridge JA, Ladanyi M, Goldring MB, Labelle (2003). The homeotic protein Six3 is a coactivator of the nuclear receptor NOR-1 and a corepressor of the fusion protein EWS/NOR-1 in human extraskeletal myxoid chondrosarcomas. Cancer research, 63(2), 449-54.
  177. Bayani J, Zielenska M, Pandita A, Al-Romaih K, Karaskova J, Harrison K, Bridge JA, Sorensen P, Thorner P, Squire J (2003). Spectral karyotyping identifies recurrent complex rearrangements of chromosomes 8, 17, and 20 in osteosarcomas. Genes, chromosomes & cancer, 36(1), 7-16.
  178. Fritsch MK, Bridge JA, Schuster AE, Perlman EJ, Argani (2003). Performance characteristics of a reverse transcriptase-polymerase chain reaction assay for the detection of tumor-specific fusion transcripts from archival tissue. Pediatric and developmental pathology, 6(1), 43-53.
  179. Gorlick R, Anderson P, Andrulis I, Arndt C, Beardsley GP, Bernstein M, Bridge J, Cheung NK, Dome JS, Ebb D, Gardner T, Gebhardt M, Grier H, Hansen M, Healey J, Helman L, Hock J, Houghton J, Houghton P, Huvos A, Khanna C, Kieran M, Kleinerman E, Ladanyi M, Lau C, Malkin D, Marina N, Meltzer P, Meyers P, Schofield D, Schwartz C, Smith MA, Toretsky J, Tsokos M, Wexler L, Wigginton J, Withrow S, Schoenfeldt M, Anderson (2003). Biology of childhood osteogenic sarcoma and potential targets for therapeutic development: meeting summary. Clinical cancer research, 9(15), 5442-53.
  180. Wang R, Titley JC, Lu YJ, Summersgill BM, Bridge JA, Fisher C, Shipley (2003). Loss of 13q14-q21 and gain of 5p14-pter in the progression of leiomyosarcoma. Modern pathology, 16(8), 778-85.
  181. Kuiper RP, Schepens M, Thijssen J, van Asseldonk M, van den Berg E, Bridge J, Schuuring E, Schoenmakers EF, van Kessel A (2003). Upregulation of the transcription factor TFEB in t(6;11)(p21;q13)-positive renal cell carcinomas due to promoter substitution. Human molecular genetics, 12(14), 1661-9.
  182. Folpe AL, McKenney JK, Bridge JA, Weiss S (2002). Sclerosing rhabdomyosarcoma in adults: report of four cases of a hyalinizing, matrix-rich variant of rhabdomyosarcoma that may be confused with osteosarcoma, chondrosarcoma, or angiosarcoma. The American journal of surgical pathology, 26(9), 1175-83.
  183. Sarosdy MF, Schellhammer P, Bokinsky G, Kahn P, Chao R, Yore L, Zadra J, Burzon D, Osher G, Bridge JA, Anderson S, Johansson SL, Lieber M, Soloway M, Flom (2002). Clinical evaluation of a multi-target fluorescent in situ hybridization assay for detection of bladder cancer. The Journal of urology, 168(5), 1950-4.
  184. Barker KT, Bevan S, Wang R, Lu YJ, Flanagan AM, Bridge JA, Fisher C, Finlayson CJ, Shipley J, Houlston R (2002). Low frequency of somatic mutations in the FH/multiple cutaneous leiomyomatosis gene in sporadic leiomyosarcomas and uterine leiomyomas. British journal of cancer, 87(4), 446-8.
  185. Feely MG, Boehm AK, Bridge RS, Krallman PA, Neff JR, Nelson M, Bridge J (2002). Cytogenetic and molecular cytogenetic evidence of recurrent 8q24.1 loss in osteochondroma. Cancer genetics and cytogenetics, 137(2), 102-7.
  186. Barr FG, Qualman SJ, Macris MH, Melnyk N, Lawlor ER, Strzelecki DM, Triche TJ, Bridge JA, Sorensen P (2002). Genetic heterogeneity in the alveolar rhabdomyosarcoma subset without typical gene fusions. Cancer research, 62(16), 4704-10.
  187. Sorensen PH, Lynch JC, Qualman SJ, Tirabosco R, Lim JF, Maurer HM, Bridge JA, Crist WM, Triche TJ, Barr F (2002). PAX3-FKHR and PAX7-FKHR gene fusions are prognostic indicators in alveolar rhabdomyosarcoma: a report from the children's oncology group. Journal of clinical oncology, 20(11), 2672-9.
  188. Batanian JR, Bridge JA, Wickert R, Vogler C, Gadre B, Huang (2002). EWS/FLI-1 fusion signal inserted into chromosome 11 in one patient with morphologic features of Ewing sarcoma, but lacking t(11;22). Cancer genetics and cytogenetics, 133(1), 72-5.
  189. Naumann S, Krallman PA, Unni KK, Fidler ME, Neff JR, Bridge J (2002). Translocation der(13;21)(q10;q10) in skeletal and extraskeletal mesenchymal chondrosarcoma. Modern pathology, 15(5), 572-6.
  190. Gisselsson D, Pålsson E, Höglund M, Domanski H, Mertens F, Pandis N, Sciot R, Dal Cin P, Bridge JA, Mandahl (2002). Differentially amplified chromosome 12 sequences in low- and high-grade osteosarcoma. Genes, chromosomes & cancer, 33(2), 133-40.
  191. Ladanyi M, Antonescu CR, Leung DH, Woodruff JM, Kawai A, Healey JH, Brennan MF, Bridge JA, Neff JR, Barr FG, Goldsmith JD, Brooks JS, Goldblum JR, Ali SZ, Shipley J, Cooper CS, Fisher C, Skytting B, Larsson (2002). Impact of SYT-SSX fusion type on the clinical behavior of synovial sarcoma: a multi-institutional retrospective study of 243 patients. Cancer research, 62(1), 135-40.
  192. Bridge JA, Liu J, Qualman SJ, Suijkerbuijk R, Wenger G, Zhang J, Wan X, Baker KS, Sorensen P, Barr F (2002). Genomic gains and losses are similar in genetic and histologic subsets of rhabdomyosarcoma, whereas amplification predominates in embryonal with anaplasia and alveolar subtypes. Genes, chromosomes & cancer, 33(3), 310-21.
  193. Antonescu CR, Tschernyavsky SJ, Decuseara R, Leung DH, Woodruff JM, Brennan MF, Bridge JA, Neff JR, Goldblum JR, Ladanyi (2001). Prognostic impact of P53 status, TLS-CHOP fusion transcript structure, and histological grade in myxoid liposarcoma: a molecular and clinicopathologic study of 82 cases. Clinical cancer research, 7(12), 3977-87.
  194. Argani P, Antonescu CR, Illei PB, Lui MY, Timmons CF, Newbury R, Reuter VE, Garvin AJ, Perez-Atayde AR, Fletcher JA, Beckwith JB, Bridge JA, Ladanyi (2001). Primary renal neoplasms with the ASPL-TFE3 gene fusion of alveolar soft part sarcoma: a distinctive tumor entity previously included among renal cell carcinomas of children and adolescents. The American journal of pathology, 159(1), 179-92.
  195. Bridge JA, Kanamori M, Ma Z, Pickering D, Hill DA, Lydiatt W, Lui MY, Colleoni GW, Antonescu CR, Ladanyi M, Morris S (2001). Fusion of the ALK gene to the clathrin heavy chain gene, CLTC, in inflammatory myofibroblastic tumor. The American journal of pathology, 159(2), 411-5.
  196. Aubry MC, Bridge JA, Wickert R, Tazelaar H (2001). Primary monophasic synovial sarcoma of the pleura: five cases confirmed by the presence of SYT-SSX fusion transcript. The American journal of surgical pathology, 25(6), 776-81.
  197. Mendlick MR, Nelson M, Pickering D, Johansson SL, Seemayer TA, Neff JR, Vergara G, Rosenthal H, Bridge J (2001). Translocation t(1;3)(p36.3;q25) is a nonrandom aberration in epithelioid hemangioendothelioma. The American journal of surgical pathology, 25(5), 684-7.
  198. Wang R, Lu YJ, Fisher C, Bridge JA, Shipley (2001). Characterization of chromosome aberrations associated with soft-tissue leiomyosarcomas by twenty-four-color karyotyping and comparative genomic hybridization analysis. Genes, chromosomes & cancer, 31(1), 54-64.
  199. McComb EN, Feely MG, Neff JR, Johansson SL, Nelson M, Bridge J (2001). Cytogenetic instability, predominantly involving chromosome 1, is characteristic of elastofibroma. Cancer genetics and cytogenetics, 126(1), 68-72.
  200. Ladanyi M, Woodruff JM, Scheithauer BW, Bridge JA, Barr FG, Goldblum JR, Fisher C, Perez-Atayde A, Dal Cin P, Fletcher CD, Fletcher J (2001). Re: O'Sullivan MJ, Kyriakos M, Zhu X, Wick MR, Swanson PE, Dehner LP, Humphrey PA, Pfeifer JD: malignant peripheral nerve sheath tumors with t(X;18). A pathologic and molecular genetic study. Mod pathol 2000;13:1336-46. Modern pathology, 14(7), 733-7.
  201. Parham DM, Roloson GJ, Feely M, Green DM, Bridge JA, Beckwith J (2001). Primary malignant neuroepithelial tumors of the kidney: a clinicopathologic analysis of 146 adult and pediatric cases from the National Wilms' Tumor Study Group Pathology Center. The American journal of surgical pathology, 25(2), 133-46.
  202. Kanamori M, Antonescu CR, Scott M, Bridge RS Jr, Neff JR, Spanier SS, Scarborough MT, Vergara G, Rosenthal HG, Bridge J (2001). Extra copies of chromosomes 7, 8, 12, 19, and 21 are recurrent in adamantinoma. The Journal of molecular diagnostics, 3(1), 16-21.
  203. Colleoni GW, Bridge JA, Garicochea B, Liu J, Filippa DA, Ladanyi (2000). ATIC-ALK: A novel variant ALK gene fusion in anaplastic large cell lymphoma resulting from the recurrent cryptic chromosomal inversion, inv(2)(p23q35). The American journal of pathology, 156(3), 781-9.
  204. Bridge JA, Sandberg A (2000). Cytogenetic and molecular genetic techniques as adjunctive approaches in the diagnosis of bone and soft tissue tumors. Skeletal radiology, 29(5), 249-58.
  205. Breiner JA, Meis-Kindblom J, Kindblom LG, McComb E, Liu J, Nelson M, Bridge J (2000). Loss of 14q and 22q in gastrointestinal stromal tumors (pacemaker cell tumors). Cancer genetics and cytogenetics, 120(2), 111-6.
  206. Safar A, Nelson M, Neff JR, Maale GE, Bayani J, Squire J, Bridge J (2000). Recurrent anomalies of 6q25 in chondromyxoid fibroma. Human pathology, 31(3), 306-11.
  207. Simons A, Schepens M, Jeuken J, Sprenger S, van de Zande G, Bjerkehagen B, Forus A, Weibolt V, Molenaar I, van den Berg E, Myklebost O, Bridge J, van Kessel AG, Suijkerbuijk (2000). Frequent loss of 9p21 (p16(INK4A)) and other genomic imbalances in human malignant fibrous histiocytoma. Cancer genetics and cytogenetics, 118(2), 89-98.
  208. Ladanyi M, Bridge J (2000). Contribution of molecular genetic data to the classification of sarcomas. Human pathology, 31(5), 532-8.
  209. Van Gele M, Kaghad M, Leonard JH, Van Roy N, Naeyaert JM, Geerts ML, Van Belle S, Cocquyt V, Bridge J, Sciot R, De Wolf-Peeters C, De Paepe A, Caput D, Speleman (2000). Mutation analysis of P73 and TP53 in Merkel cell carcinoma. British journal of cancer, 82(4), 823-6.
  210. Bridge JA, Fidler ME, Neff JR, Degenhardt J, Wang M, Walker C, Dorfman HD, Baker KS, Seemayer T (1999). Adamantinoma-like Ewing's sarcoma: genomic confirmation, phenotypic drift. The American journal of surgical pathology, 23(2), 159-65.
  211. Bosilevac JM, Olsen RJ, Bridge JA, Hinrichs S (1999). Tumor cell viability in clear cell sarcoma requires DNA binding activity of the EWS/ATF1 fusion protein. The Journal of biological chemistry, 274(49), 34811-8.
  212. Page TJ, Mata JE, Bridge JA, Siebler JC, Neff JR, Iversen P (1999). The cytotoxic effects of single-stranded telomere mimics on OMA-BL1 cells. Experimental cell research, 252(1), 41-9.
  213. Rao VH, Singh RK, Delimont DC, Schaefer GB, Bridge JA, Neff JR, Sanger WG, Sappenfield JW, Buehler BA, Finnell R (1999). Interleukin-1beta upregulates MMP-9 expression in stromal cells of human giant cell tumor of bone. Journal of interferon & cytokine research, 19(10), 1207-17.
  214. Rao VH, Singh RK, Delimont DC, Finnell RH, Bridge JA, Neff JR, Garvin BP, Pickering DL, Sanger WG, Buehler BA, Schaefer G (1999). Transcriptional regulation of MMP-9 expression in stromal cells of human giant cell tumor of bone by tumor necrosis factor-alpha. International journal of oncology, 14(2), 291-300.
  215. Breiner JA, Nelson M, Bredthauer BD, Neff JR, Bridge J (1999). Trisomy 8 and trisomy 14 in plantar fibromatosis. Cancer genetics and cytogenetics, 108(2), 176-7.
  216. Buresh CJ, Seemayer TA, Nelson M, Neff JR, Dorfman HD, Bridge (1999). t(X;4)(q22;q31.3) in giant cell reparative granuloma. Cancer genetics and cytogenetics, 115(1), 80-1.
  217. Bridge JA, Swarts SJ, Buresh C, Nelson M, Degenhardt JM, Spanier S, Maale G, Meloni A, Lynch JC, Neff J (1999). Trisomies 8 and 20 characterize a subgroup of benign fibrous lesions arising in both soft tissue and bone. The American journal of pathology, 154(3), 729-33.
  218. Safar A, Wickert R, Nelson M, Neff JR, Bridge J (1998). Characterization of a variant SYT-SSX1 synovial sarcoma fusion transcript. Diagnostic molecular pathology, 7(5), 283-7.
  219. Aue G, Hedges LK, Schwartz HS, Bridge JA, Neff JR, Butler M (1998). Clear cell sarcoma or malignant melanoma of soft parts: molecular analysis of microsatellite instability with clinical correlation. Cancer genetics and cytogenetics, 105(1), 24-8.
  220. Petit MM, Swarts S, Bridge JA, Van de Ven W (1998). Expression of reciprocal fusion transcripts of the HMGIC and LPP genes in parosteal lipoma. Cancer genetics and cytogenetics, 106(1), 18-23.
  221. Bridge JA, Nelson M, Orndal C, Bhatia P, Neff J (1998). Clonal karyotypic abnormalities of the hereditary multiple exostoses chromosomal loci 8q24.1 (EXT1) and 11p11-12 (EXT2) in patients with sporadic and hereditary osteochondromas. Cancer, 82(9), 1657-63.
  222. Lawlor ER, Mathers JA, Bainbridge T, Horsman DE, Kawai A, Healey JH, Huvos AG, Bridge JA, Ladanyi M, Sorensen P (1998). Peripheral primitive neuroectodermal tumors in adults: documentation by molecular analysis. Journal of clinical oncology, 16(3), 1150-7.
  223. Swarts SJ, Neff JR, Johansson SL, Nelson M, Bridge J (1998). Significance of abnormalities of chromosomes 5 and 8 in chondroblastoma. Clinical orthopaedics and related research, (349), 189-93.
  224. Bridge JA, Roberts CA, Degenhardt J, Walker C, Lackner R, Linder (1998). Low-level chromosome 12 amplification in a primary lipoma of the lung: evidence for a pathogenetic relationship with common adipose tissue tumors. Archives of pathology & laboratory medicine, 122(2), 187-90.
  225. Weibolt VM, Buresh CJ, Roberts CA, Suijkerbuijk RF, Pickering DL, Neff JR, Bridge J (1998). Involvement of 3q21 in nodular fasciitis. Cancer genetics and cytogenetics, 106(2), 177-9.
  226. Day SJ, Nelson M, Rosenthal H, Vergara GG, Bridge J (1997). Der(16)t(1;16)(q21;q13) as a secondary structural aberration in yet a third sarcoma, extraskeletal myxoid chondrosarcoma. Genes, chromosomes & cancer, 20(4), 425-7.
  227. Rao VH, Singh RK, Bridge JA, Neff JR, Schaefer GB, Delimont DC, Dunn CM, Sanger WG, Buehler BA, Sawaya R, Nicolson GL, Rao J (1997). Regulation of MMP-9 (92 kDa type IV collagenase/gelatinase B) expression in stromal cells of human giant cell tumor of bone. Clinical & experimental metastasis, 15(4), 400-9.
  228. Cihak RA, Lydiatt WM, Lydiatt DD, Bridge J (1997). Synovial sarcoma of the head and neck: chromosomal translation (X;18) as a diagnostic aid. Head & neck, 19(6), 549-53.
  229. McComb EN, Neff JR, Johansson SL, Nelson M, Bridge J (1997). Chromosomal anomalies in a case of proliferative myositis. Cancer genetics and cytogenetics, 98(2), 142-4.
  230. Krause AK, Hinrichs SH, Orndal C, DeBoer J, Neff JR, Bridge J (1997). Characterization of a human myxoid malignant fibrous histiocytoma cell line, OH931. Cancer genetics and cytogenetics, 94(2), 138-43.
  231. Brody RI, Ueda T, Hamelin A, Jhanwar SC, Bridge JA, Healey JH, Huvos AG, Gerald WL, Ladanyi (1997). Molecular analysis of the fusion of EWS to an orphan nuclear receptor gene in extraskeletal myxoid chondrosarcoma. The American journal of pathology, 150(3), 1049-58.
  232. McComb EN, McComb RD, DeBoer JM, Neff JR, Bridge J (1996). Cytogenetic analysis of a malignant triton tumor and a malignant peripheral nerve sheath tumor and a review of the literature. Cancer genetics and cytogenetics, 91(1), 8-12.
  233. Swarts S, Wisecarver J, Bridge J (1996). Significance of extra copies of chromosome 20 and the long arm of chromosome 2 in hepatoblastoma. Cancer genetics and cytogenetics, 91(1), 65-7.
  234. McComb EN, Johansson SL, Neff JR, Nelson M, Bridge J (1996). Chromosomal anomalies exclusive of telomeric associations in giant cell tumor of bone. Cancer genetics and cytogenetics, 88(2), 163-6.
  235. Bridge J (1996). Cytogenetics and experimental models. Current opinion in oncology, 8(4), 284-8.
  236. Swarts SJ, Neff JR, Johansson SL, Bridge J (1996). Cytogenetic analysis of dedifferentiated chondrosarcoma. Cancer genetics and cytogenetics, 89(1), 49-51.
  237. Roberts CA, Seemayer TA, Neff JR, Alonso A, Nelson M, Bridge J (1996). Translocation (X;18) in primary synovial sarcoma of the lung. Cancer genetics and cytogenetics, 88(1), 49-52.
  238. Wang Z, Taylor AK, Bridge J (1996). FMR1 fully expanded mutation with minimal methylation in a high functioning fragile X male. Journal of medical genetics, 33(5), 376-8.
  239. Rao VH, Bridge JA, Neff JR, Schaefer GB, Buehler BA, Vishwanatha JK, Pollock RE, Nicolson GL, Yamamoto M, Gokaslam Z (1995). Expression of 72 kDa and 92 kDa type IV collagenases from human giant-cell tumor of bone. Clinical & experimental metastasis, 13(6), 420-6.
  240. Bridge JA, DeBoer J, Walker CW, Neff J (1995). Translocation t(3;12)(q28;q14) in parosteal lipoma. Genes, chromosomes & cancer, 12(1), 70-2.
  241. Bridge J (1995). Cytogenetics and experimental models of sarcomas. Current opinion in oncology, 7(4), 333-9.
  242. Bridge JA, Pickering D, Neff J (1994). Cytogenetic and molecular cytogenetic analysis of sacral chordoma. Cancer genetics and cytogenetics, 75(1), 23-5.
  243. Sinovic J, Bridge J (1994). Translocation (2;17) in recurrent dermatofibrosarcoma protuberans. Cancer genetics and cytogenetics, 75(2), 156-7.
  244. Bridge JA, Dembinski A, DeBoer J, Travis J, Neff J (1994). Clonal chromosomal abnormalities in osteofibrous dysplasia. Implications for histopathogenesis and its relationship with adamantinoma. Cancer, 73(6), 1746-52.
  245. Bridge JA, DeBoer J, Travis J, Johansson SL, Elmberger G, Noel SM, Neff J (1994). Simultaneous interphase cytogenetic analysis and fluorescence immunophenotyping of dedifferentiated chondrosarcoma. Implications for histopathogenesis. The American journal of pathology, 144(2), 215-20.
  246. Travis JA, Sandberg AA, Neff JR, Bridge J (1994). Cytogenetic findings in malignant triton tumor. Genes, chromosomes & cancer, 9(1), 1-7.
  247. Bridge JA, Bhatia PS, Anderson JR, Neff J (1993). Biologic and clinical significance of cytogenetic and molecular cytogenetic abnormalities in benign and malignant cartilaginous lesions. Cancer genetics and cytogenetics, 69(2), 79-90.
  248. Tayyeb MT, Neff JR, Bridge J (1993). A case report of fibrolipoma with t(12;16)(q13;q24). Cancer genetics and cytogenetics, 67(2), 145-6.
  249. Bridge J (1993). Cytogenetic and molecular cytogenetic techniques in orthopaedic surgery. The Journal of bone and joint surgery. American volume, 75(4), 606-14.
  250. Meloni AM, Bridge J, Sandberg A (1992). Reviews on chromosome studies in urological tumors. I. Renal tumors. The Journal of urology, 148(2 Pt 1), 253-65.
  251. Travis JA, Bridge J (1992). Significance of both numerical and structural chromosomal abnormalities in clear cell sarcoma. Cancer genetics and cytogenetics, 64(2), 104-6.
  252. Stephenson CF, Bridge JA, Sandberg A (1992). Cytogenetic and pathologic aspects of Ewing's sarcoma and neuroectodermal tumors. Human pathology, 23(11), 1270-7.
  253. DeBoer JM, Neff JR, Bridge J (1992). Cytogenetics of sacral chordoma. Cancer genetics and cytogenetics, 64(1), 95-6.
  254. Bridge JA, Persons DL, Neff JR, Bhatia (1992). Clonal karyotypic aberrations in enchondromas. Cancer detection and prevention, 16(4), 215-9.
  255. Sinovic JF, Bridge JA, Neff J (1992). Ring chromosome in parosteal osteosarcoma. Clinical and diagnostic significance. Cancer genetics and cytogenetics, 62(1), 50-2.
  256. Dembinski A, Bridge JA, Neff JR, Berger C, Sandberg A (1992). Trisomy 2 in proliferative fasciitis. Cancer genetics and cytogenetics, 60(1), 27-30.
  257. Bridge JA, Sreekantaiah C, Mouron B, Neff JR, Sandberg AA, Wolman S (1992). Clonal chromosomal abnormalities in desmoid tumors. Implications for histopathogenesis. Cancer, 69(2), 430-6.
  258. Sandberg AA, Bridge J (1992). Techniques in cancer cytogenetics: an overview and update. Cancer investigation, 10(2), 163-72.
  259. Bridge JA, Neff JR, Mouron B (1992). Giant cell tumor of bone. Chromosomal analysis of 48 specimens and review of the literature. Cancer genetics and cytogenetics, 58(1), 2-13.
  260. Bridge JA, Sreekantaiah C, Neff JR, Sandberg A (1991). Cytogenetic findings in clear cell sarcoma of tendons and aponeuroses. Malignant melanoma of soft parts. Cancer genetics and cytogenetics, 52(1), 101-6.
  261. Meloni A, Morgan R, Bridge J, Erling MA, Lewin RJ, Sandberg A (1991). Cytogenetic findings in typical and atypical meningioma. Cancer genetics and cytogenetics, 51(1), 35-9.
  262. Bridge J, Leong SP, Burgess AC, Thompson F, Trent J (1991). Examination of clonal variants from human malignant melanoma studied by chromosome banding analysis. Melanoma research, 1(4), 289-96.
  263. Persons DL, Bridge JA, Neff J (1991). Cytogenetic analysis of two sacral chordomas. Cancer genetics and cytogenetics, 56(2), 197-201.
  264. Bridge JA, Mouron BJ, Neff JR, Bhatia P (1991). Significance of chromosomal abnormalities in a malignant giant cell tumor of bone. Cancer genetics and cytogenetics, 57(1), 87-92.
  265. Sreekantaiah C, Bridge JA, Rao UN, Neff JR, Sandberg A (1991). Clonal chromosomal abnormalities in hemangiopericytoma. Cancer genetics and cytogenetics, 54(2), 173-81.
  266. Pfeifer FM, Bridge JA, Neff JR, Mouron B (1991). Cytogenetic findings in aneurysmal bone cysts. Genes, chromosomes & cancer, 3(6), 416-9.
  267. Bridge JA, Neff JR, Borek DA, Hackbarth D (1990). Primary skeletal Ewing's sarcoma in Down syndrome. Cancer genetics and cytogenetics, 47(1), 61-8.
  268. Bridge JA, Neff JR, Bhatia PS, Sanger WG, Murphey M (1990). Cytogenetic findings and biologic behavior of giant cell tumors of bone. Cancer, 65(12), 2697-703.
  269. Bridge JA, Neff JR, Sandberg A (1990). Cytogenetic analysis of dermatofibrosarcoma protuberans. Cancer genetics and cytogenetics, 49(2), 199-202.
  270. Bridge JA, Sanger WG, Neff JR, Hess M (1990). Cytogenetic findings in a primary malignant fibrous histiocytoma of bone and the lung metastasis. Pathology, 22(1), 16-9.
  271. Bridge JA, Neff JR, Bhatia PS, Sanger W (1990). Cytogenetic analysis of giant cell tumors of bone; diagnostic and prognostic implications. La Chirurgia degli organi di movimento, 75(1 Suppl), 187-8.
  272. Kepes JJ, Bridge JA, Flasschoen (1990). Penetration of neuronal perikarya by capillaries in chronic limbic encephalitis. Journal of neuropathology and experimental neurology, 49(1), 64-70.
  273. Bridge JA, Borek DA, Neff JR, Huntrakoon (1990). Chromosomal abnormalities in clear cell sarcoma. Implications for histogenesis. American journal of clinical pathology, 93(1), 26-31.
  274. Bridge JA, Sanger WG, Neff J (1989). Translocations involving chromosomes 2 and 13 in benign and malignant cartilaginous neoplasms. Cancer genetics and cytogenetics, 38(1), 83-8.
  275. Bridge JA, McManus BM, Remmenga J, Cuppage F (1989). Complete heart block in the 18p--syndrome. Congenital calcification of the atrioventricular node. Archives of pathology & laboratory medicine, 113(5), 539-41.
  276. Bridge J, Patil S, Peterson J, Speaks S, Fatemi C, Williamson R, Sanger (1988). Two double translocation families. Kansas medicine, 89(2), 46-8.
  277. Bridge JA, Bridge RS, Borek DA, Shaffer B, Norris C (1988). Translocation t(X;18) in orofacial synovial sarcoma. Cancer, 62(5), 935-7.
  278. Bridge JA, Sanger WG, Shaffer B, Neff J (1987). Cytogenetic findings in malignant fibrous histiocytoma. Cancer genetics and cytogenetics, 29(1), 97-102.
  279. Sanger WG, Armitage JO, Bridge J, Weisenburger DD, Fordyce R, Purtilo D (1987). Initial and subsequent cytogenetic studies in malignant lymphoma. Cancer, 60(12), 3014-9.
  280. Bridge J, Sanger W, Mosher G, Buehler B, Nelson R, Welsh M, Newland J, Kafka (1985). Partial deletion of distal 17q. American journal of medical genetics, 21(2), 225-9.
  281. Bridge J, Sanger W, Mosher G, Buehler B, Hearty C, Olney A, Fordyce (1985). Partial duplication of distal 17q. American journal of medical genetics, 22(2), 229-35.

Review

  1. Sotiriou S, Chatzopoulos K, Charville GW, Bean GR, Michal M, Gross JM, Bridge JA, Gardner JM, Agaimy A, Ng TL, Cloutier JM, Saoud C, Linos (2025). Dermatofibrosarcoma protuberans with PDGFD rearrangements: a case series featuring a novel EMILIN1::PDGFD fusion and comprehensive literature review. Virchows Archiv, 487(2), 349-361.
  2. Sta Ines FMG, Marketkar S, Ng S, Manrai P, James Sung C, Bridge JA, Singh (2025). Myoid Hamartoma of the Breast With HMGA2 Rearrangement and Associated In-Situ and Invasive Carcinoma: Case Report and Review of Literature. International journal of surgical pathology, 33(3), 689-699.
  3. Whaley RD, Agaimy A, Bridge JA, Stoehr R, Din NU, Gagan J, Rampisela D, Folpe AL, Bishop J (2024). Xanthogranulomatous epithelial tumors/keratin-positive giant cell-rich tumors involving the head and neck: report of seven cases and review of the literature. Virchows Archiv, 485(4), 605-613.
  4. Amin SE, Lewis JS Jr, Bridge JA, Hang JF, Naik U, Bishop JA, Saluja (2024). DEK::AFF2 Fusion-Associated Squamous Cell Carcinoma: A Case Series with Literature Review on an Emerging and Challenging Entity. Head and neck pathology, 18(1), 86.
  5. McMullen PD, Bridge JA, Blair EA, Yang CW, Collins J, Cipriani NA (2019). Aneurysmal Bone Cyst of the Maxillary Sinus with USP6 Rearrangement: Case Report of a Rare Entity and Review of the Literature. [Review]. Head Neck Pathol, 13, (3), 281-285.
  6. Banach BS, Antic T, Bridge JA, Cipriani NA, Frye L, Krausz TN, Biernacka A (2019). Fine-needle aspiration of dermatofibrosarcoma protuberans metastasizing to hemithorax with superior vena cava compression: Case report and literature review. [Review]. Diagn Cytopathol, 47, (8), 797-802.
  7. Torabi A, Corral J, Gatalica Z, Swensen J, Moraveji S, Bridge JA (2017). Primary renal sclerosing epithelioid fibrosarcoma: a case report and review of the literature. [Review]. Pathology, 49, (4), 447-450.
  8. Nagarajan R, Bartley AN, Bridge JA, Jennings LJ, Kamel-Reid S, Kim A, Lazar AJ, Lindeman NI, Moncur J, Rai AJ, Routbort MJ, Vasalos P, Merker JD (2017). A Window Into Clinical Next-Generation Sequencing-Based Oncology Testing Practices. [Review]. Arch Pathol Lab Med, 141, (12), 1679-1685.
  9. Cajaiba MM, Jennings LJ, Rohan SM, Perez-Atayde AR, Marino-Enriquez A, Fletcher JA, Geller JI, Leuer KM, Bridge JA, Perlman EJ (2016). ALK-rearranged renal cell carcinomas in children. [Review]. Genes Chromosomes Cancer, 55, (5), 442-51.
  10. Lyle PL, Bridge JA, Simpson JF, Cates JM, Sanders ME (2016). Liposarcomatous differentiation in malignant phyllodes tumours is unassociated with MDM2 or CDK4 amplification. [Review]. Histopathology, 68, (7), 1040-5.
  11. Fang D, Gan H, Lee JH, Han J, Wang Z, Riester SM, Jin L, Chen J, Zhou H, Wang J, Zhang H, Yang N, Bradley EW, Ho TH, Rubin BP, Bridge JA, Thibodeau SN, Ordog T, Chen Y, van Wijnen AJ, Oliveira AM, Xu RM, Westendorf JJ, Zhang Z (2016). The histone H3.3K36M mutation reprograms the epigenome of chondroblastomas. [Review]. Science, 352, (6291), 1344-8.
  12. Ertoy Baydar D, Kosemehmetoglu K, Aydin O, Bridge JA, Buyukeren B, Aki FT (2015). Primary sclerosing epithelioid fibrosarcoma of kidney with variant histomorphologic features: report of 2 cases and review of the literature. [Review]. Diagn Pathol, 10, 186.
  13. Sandberg AA, Bridge J (2003). Updates on the cytogenetics and molecular genetics of bone and soft tissue tumors: osteosarcoma and related tumors. Cancer genetics and cytogenetics, 145(1), 1-30.
  14. Sandberg AA, Bridge J (2003). Updates on the cytogenetics and molecular genetics of bone and soft tissue tumors. Dermatofibrosarcoma protuberans and giant cell fibroblastoma. Cancer genetics and cytogenetics, 140(1), 1-12.
  15. Sandberg AA, Bridge J (2003). Updates on the cytogenetics and molecular genetics of bone and soft tissue tumors: chondrosarcoma and other cartilaginous neoplasms. Cancer genetics and cytogenetics, 143(1), 1-31.
  16. Sandberg AA, Bridge J (2002). Updates on the cytogenetics and molecular genetics of bone and soft tissue tumors. desmoplastic small round-cell tumors. Cancer genetics and cytogenetics, 138(1), 1-10.
  17. Sandberg AA, Bridge J (2002). Updates on the cytogenetics and molecular genetics of bone and soft tissue tumors. gastrointestinal stromal tumors. Cancer genetics and cytogenetics, 135(1), 1-22.
  18. Sandberg A, Bridge (2002). Updates on the cytogenetics and molecular genetics of bone and soft tissue tumors: alveolar soft part sarcoma. Cancer genetics and cytogenetics, 136(1), 1-9.
  19. Sandberg AA, Bridge J (2002). Updates on the cytogenetics and molecular genetics of bone and soft tissue tumors. Synovial sarcoma. Cancer genetics and cytogenetics, 133(1), 1-23.
  20. Sandberg AA, Bridge J (2002). Updates on the cytogenetics and molecular genetics of bone and soft tissue tumors: congenital (infantile) fibrosarcoma and mesoblastic nephroma. Cancer genetics and cytogenetics, 132(1), 1-13.
  21. Sandberg AA, Bridge J (2001). Updates on the cytogenetics and molecular genetics of bone and soft tissue tumors: clear cell sarcoma (malignant melanoma of soft parts). Cancer genetics and cytogenetics, 130(1), 1-7.
  22. Sandberg AA, Bridge J (2001). Updates on the cytogenetics and molecular genetics of bone and soft tissue tumors. Mesothelioma. Cancer genetics and cytogenetics, 127(2), 93-110.
  23. Sandberg AA, Bridge J (2000). Updates on cytogenetics and molecular genetics of bone and soft tissue tumors: Ewing sarcoma and peripheral primitive neuroectodermal tumors. Cancer genetics and cytogenetics, 123(1), 1-26.
  24. Sandberg AA, Bridge J (2000). Updates on cytogenetics and molecular genetics of bone and soft tissue tumors: Ewing sarcoma and peripheral primitive neuroectodermal tumors. Cancer genetics and cytogenetics, 123(1), 1-26.
  25. Feely MG, Fidler ME, Nelson M, Neff JR, Bridge J (2000). Cytogenetic findings in a case of epithelioid sarcoma and a review of the literature. Cancer genetics and cytogenetics, 119(2), 155-7.
  26. Swarts SJ, Neff JR, Nelson M, Johansson S, Bridge J (1997). Chromosomal abnormalities in low grade chondrosarcoma and a review of the literature. Cancer genetics and cytogenetics, 98(2), 126-30.
  27. Bridge JA, Nelson M, McComb E, McGuire MH, Rosenthal H, Vergara G, Maale GE, Spanier S, Neff J (1997). Cytogenetic findings in 73 osteosarcoma specimens and a review of the literature. Cancer genetics and cytogenetics, 95(1), 74-87.
  28. Bridge JA, Rosenthal H, Sanger WG, Neff J (1989). Desmoplastic fibroma arising in fibrous dysplasia. Chromosomal analysis and review of the literature. Clinical orthopaedics and related research, (247), 272-8.

Case Report

  1. Murphy LD, Orman GM, Bridge JA, Bajaj G, Gardner JM, Douglass DP (2020). Primary superficial Ewing sarcoma: A unique entity? A case report including novel findings of ELF3 and TNFRSF14 copy number loss. J Cutan Pathol, 47(10), 970-975.
  2. Keung ES, Souers RJ, Bridge JA, Faquin WC, Graham RP, Hameed MR, Lewis JS Jr, Merker JD, Vasalos P, Moncur JT (2020). Comparative Performance of High-Risk Human Papillomavirus RNA and DNA In Situ Hybridization on College of American Pathologists Proficiency Tests. Arch Pathol Lab Med, 144(3), 344-349.
  3. Dawson K, Bridge JA, Sumegi J, Royce T, Gardner JM, Shalin SC (2020). Epithelioid Fibrous Histiocytoma With Dot-Like Perinuclear ALK Expression and PRKAR2A-ALK Fusion. Am J Dermatopathol, 42(11), 861-864.
  4. Linos K, Kerr DA, Baker M, Wong S, Henderson E, Sumegi J, Bridge JA (2020). Superficial malignant ossifying fibromyxoid tumors harboring the rare and recently described ZC3H7B-BCOR and PHF1-TFE3 fusions. J Cutan Pathol, 47(10), 934-945.
  5. McComb EN, Neff JR, Johansson SL, Nelson M, Bridge J (1997). Chromosomal anomalies in a case of proliferative myositis. Cancer genetics and cytogenetics, 98(2), 142-4.
  6. Kenny-Moynihan MB, Hagen J, Richman B, McIntosh DG, Bridge J (1996). Loss of an X chromosome in aggressive angiomyxoma of female soft parts: a case report. Cancer genetics and cytogenetics, 89(1), 61-4.

Letter

  1. Nicholas BA, Purohit R, Woods AD, Kannan K, Srinivasa G, Bridge JA, Kim JA, Keller C (2023). BCR-ABL is enriched in S- and G(2)-cell cycle phases. [Letter to the editor]. Leuk Res, 126, 107036.
  2. Rimm DL, Han G, Taube JM, Yi ES, Bridge JA, Flieder DB, Homer R, Roden AC, Hirsch FR, Wistuba II, Pusztai L (2019). Reanalysis of the NCCN PD-L1 companion diagnostic assay study for lung cancer in the context of PD-L1 expression findings in triple-negative breast cancer. [Letter to the editor]. Breast Cancer Res, 21(1), 72.
  3. Linos K, Bridge JA, Edgar MA (2014). MUC 4-negative FUS-CREB3L2 rearranged low-grade fibromyxoid sarcoma. [Letter to the editor]. Histopathology, 65(5), 722-4.
  4. Ganesan J, Spanier S, Bridge J (2000). Cytogenetic findings in a case of brown tumor associated with hyperparathyroidism. Cancer genetics and cytogenetics, 119(2), 165-6.
  5. Bridge JA, Meloni AM, Neff JR, Deboer J, Pickering D, Dalence C, Jeffrey B, Sandberg A (1996). Deletion 5q in desmoid tumor and fluorescence in situ hybridization for chromosome 8 and/or 20 copy number. Cancer genetics and cytogenetics, 92(2), 150-1.
  6. Bridge JA, Shaffer B, Neff JR, Sanger WG, Moran (1988). A complex translocation involving chromosomes 12 and 16 in a metastatic myxoid liposarcoma. Cancer genetics and cytogenetics, 34(1), 119-20.